Literature DB >> 21550745

A diffusion gradient optimization framework for spinal cord diffusion tensor imaging.

Shantanu Majumdar1, David C Zhu, Satish S Udpa, L Guy Raguin.   

Abstract

The uncertainty in the estimation of diffusion model parameters in diffusion tensor imaging (DTI) can be reduced by optimally selecting the diffusion gradient directions utilizing some prior structural information. This is beneficial for spinal cord DTI, where the magnetic resonance images have low signal-to-noise ratio and thus high uncertainty in diffusion model parameter estimation. Presented is a gradient optimization scheme based on D-optimality, which reduces the overall estimation uncertainty by minimizing the Rician Cramer-Rao lower bound of the variance of the model parameter estimates. The tensor-based diffusion model for DTI is simplified to a four-parameter axisymmetric DTI model where diffusion transverse to the principal eigenvector of the tensor is assumed isotropic. Through simulations and experimental validation, we demonstrate that an optimized gradient scheme based on D-optimality is able to reduce the overall uncertainty in the estimation of diffusion model parameters for the cervical spinal cord and brain stem white matter tracts.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21550745     DOI: 10.1016/j.mri.2011.02.025

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

1.  Multiple-echo diffusion tensor acquisition technique (MEDITATE) on a 3T clinical scanner.

Authors:  Steven H Baete; Gene Cho; Eric E Sigmund
Journal:  NMR Biomed       Date:  2013-07-05       Impact factor: 4.044

2.  Usefulness of diffusion tensor MR imaging in the assessment of intramedullary changes of the cervical spinal cord in different stages of degenerative spine disease.

Authors:  Anna Banaszek; Joanna Bladowska; Paweł Szewczyk; Przemysław Podgórski; Marek Sąsiadek
Journal:  Eur Spine J       Date:  2014-05-11       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.